FDA enforcement authorities bill
Rep. Dingell (D-Mich.) responds to food industry opposition to the legislation by asking FDA Commissioner Kessler July 26 to make agency files available to his Oversight Subcommittee staff so that they can update "the status of the FDA's inspections of food production, importation and distribution." Fifteen food-related trade associations have written to Congress opposing HR 2597, bringing to 38 the number of associations for FDA-regulated industries that have expressed opposition to the bill ("The Pink Sheet" June 24, T&G-1). Dingell noted that a 1989 subcommittee staff report documents "FDA's limited inspectional resources, deficiencies in existing legislation and an antiquated computer system" for industry monitoring.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth